Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
'Tis the Season… for Performance Reviews Performance reviews, often seen as dreadful, can become valuable opportunities for feedback and growth when integrated into a well-structured…
Read More →Joseph Payne on why analytics, investment, and mindset will define what comes next Introduction In advanced therapies, the conversation often centers on what is possible—new modalities, new platforms, new ways of treating disease. But possibility alone does not move therapies forward. Progress depends on something more practical: what the industry chooses to invest in, support, […]
Introduction In advanced therapies, there’s a growing expectation that process can solve everything. Standardize the inputs, control the steps, optimize the system—and the outcome should follow. But biology doesn’t always cooperate. As cell and gene therapies become more complex, the limits of that control are becoming harder to ignore, surfacing not as isolated issues but […]
Jennifer Hayne on the operational realities behind successful development In biopharma, programs rarely stall because the science doesn’t work. More often, they slow down because something wasn’t fully understood early enough—something that only becomes visible once timelines tighten, partners are involved, and decisions carry real operational weight. The gap between what a company believes it […]
Christopher Larson on the operational realities behind QC in advanced therapies In cell and gene therapy, scaling is often framed as a technical problem—more capacity, more automation, more throughput. But in Quality Control, the challenge is rarely just technical. It is operational, and it becomes more visible as organizations grow. Systems don’t usually fail first. […]
Cat Willis on the responsibility and reality behind releasing advanced therapies Introduction In advanced therapies, innovation does not reach patients on its own. No matter how promising the science, no matter how advanced the process, every therapy must pass through a final decision point before it leaves the facility. That decision sits with Quality Control. […]
Techfrederick's 10-year milestone signals a shift from emergence to organization—at a moment when regional ecosystems matter more than ever.
Sumana is a strategic planner who likes to think about the big picture, lead projects with innovative strategies, and focus on continuous improvement. A meticulous worker with experience working in a collaborative environment and managing multiple resources. Skilled in learning new concepts and adapting to transforming work environments. Passionate about leveraging my expertise to solve […]
BALTIMORE, April 23, 2026 /PRNewswire/ — Neurava Inc., an innovative medtech startup focused on advanced wearable monitoring solutions for epilepsy, today announced that it has been awarded a $4 million NIH Blueprint MedTech Optimizer award to support the development of a Sudden Unexpected Death in Epilepsy (SUDEP) risk stratification and forecasting algorithm. The up-to four-year award will […]
If you work in life sciences in the Mid-Atlantic—or want to—May 7 should already be on your calendar. The ISPE Chesapeake Bay Area (CBA) Mid-Atlantic Science & Tech Showcase (MAST), the chapter’s signature annual event, returns to Baltimore for its second year. What started as a strong debut is quickly establishing itself as one of […]
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
